do people gain weight back after stopping glp 1 Understanding semaglutide (GLP-1 RA): Are they the right choice for loss? Surgeon's Warning About Weight Gain

Advances in Gerontology, 26 (1), 20-37

Fodoreyeva et al

Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials

Understanding the epidemiological patterns and etiological factors is essential for optimizing diagnosis and management strategies

Photo Credit: Adam Fisher, Baldwin Publishing 185 mins This lighter version of pot pie delivers creamy, comforting taste without overdoing it